| (1) If the patient is suspected to have a history or is complicated with stroke/transient ischemic attack (TIA), coronary artery disease (CAD), arrhythmia (such as atrial fibrillation), aortic disease, or peripheral arterial disease (PAD) |
| (2) Hypertension |
| Suspected secondary hypertension (early incidence, acute incidence, etc.), pregnancy‐induced hypertension, hypertensive emergency or urgency (untreated diastolic blood pressure ≥ 120 mmHg), treatment‐resistant hypertension (≥ 180/110 mmHg despite treatment or not achieving antihypertensive goal even with concomitant therapy with 3 drugs) |
| (3) Diabetes mellitus |
| Type 1 DM, HbA1c ≥ 8.0%, fasting blood glucose ≥ 200 mg/dL (or non‐fasting blood glucose ≥ 300 mg/dL), acute complications (hyperglycemic emergency), or gestational diabetes |
| (4) Dyslipidemia: |
| LDL‐C ≥ 180 mg/dL, HDL‐C ＜30 mg/dL, fasting TG ≥ 500 mg/dL, non‐HDL‐C ≥ 210 mg/dL, or suspected primary hyperlipidemia or secondary dyslipidemia |
| (5) Chronic kidney disease (CKD): |
| CKD patients with proteinuria and hematuria |
| eGFR ＜45 ml/min/1.73 m2 (G3b to 5 ) or proteinuria category A3 (urine albumin/ Cr ratio ＞300 mg/gCr in diabetes, urine protein/ Cr ratio ＞0.5 g/Cr otherwise). For patients under 40 years of age or in the A2 category (Urine albumin/Cr ratio 30-299 mg/gCr for diabetes, urine protein/Cr ratio 0.15-0.49 g/Cr for other conditions), referral should be made even if the eGFR is 45-59. |
| (6) Obesity: |
| Severe obesity (BMI ≥ 35). Suspected secondary obesity (symptomatic obesity) |
